Package Insert: Information for the User
Insucor 2.5 mg Tablets
nebivolol
Read this package insert carefully before you start taking this medicine, because it contains important information for you.
6. Contents of the pack and additional information
Insucor contains nebivolol, a cardiovascular medication, belonging to the group of selective beta-blockers (with selective activity in the cardiovascular system). It prevents an increase in heart rate, and controls the force of heart pumping. It also exerts a dilating action on blood vessels, which in turn contributes to reducing blood pressure.
It is used for the treatment of high blood pressure (hypertension).
Insucor is also used for the treatment of mild to moderate chronic heart failure in patients 70 years of age or older, administered in combination with other medications.
Do not takeInsucor
•if you are allergic to nebivolol or any of the other ingredients of this medication (listed in section6).
•if you have any of the following conditions:
-low blood pressure
-serious circulation problems in arms or legs
-slow heart rate (less than 60 beats per minute)
-other serious heart rhythm disorders (e.g. second- and third-degree atrioventricular block, cardiac conduction disorders).
-heart failure, which has recently worsened or is being treated with intravenous medication to help the heart work, after suffering a circulatory collapse due to acute heart failure.
-asthma or breathing difficulties (current or past), phaeochromocytoma, a tumor located in the upper part of the kidneys (adrenal glands) that is not being treated.
-liver dysfunction
-metabolic disorder (metabolic acidosis), for example, diabetic ketoacidosis
Warnings and precautions
Consult your doctor or pharmacist before starting to takeInsucor.
Inform your doctorif you have or develop any of the following problems:
•abnormally slow heart rate
•chest pain due to spontaneous spasm of the coronary arteries, known as Prinzmetal's angina
•chronic heart failure without treatment
•first-degree heart block (a mild cardiac conduction disorder that affects the heart rhythm)
•poor circulation in arms or legs, such as Raynaud's disease or syndrome, or walking pain similar to a cramp
•chronic respiratory problems
•diabetes: this medication has no effect on blood sugar levels, but may mask warning signs of hypoglycemia (e.g. palpitations, rapid heart rate) and may increase the risk of severe hypoglycemia when used with certain types of diabetes medications called sulfonylureas (e.g. glibenclamide, glimepiride, glipizide, gliquidone, gliclazide, tolbutamide)
•hyperthyroidism: this medication may mask symptoms of rapid heart rate due to this condition
•allergy: this medication may intensify your reaction to pollen or other substances to which you are allergic
•psoriasis, a skin disease characterized by scaly pink patches
•if you are undergoing surgery, inform your anesthesiologist that you are taking this medication
If you have severe kidney problems, consult your doctor before taking Insucor to treat heart failure.
At the start of treatment for chronic heart failure, you should be regularly monitored by a doctor (see section 3).
This treatment should not be stopped abruptly, unless clearly indicated and evaluated by your doctor (see section 3).
Children and adolescents
Insucor is not recommended for use in children and adolescents due to the lack of data on the use of this medication in this type of patient.
Other medications and Insucor
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication
Inform your doctor if, in addition to Insucor, you are using any of the following medications:
All these medications, like nebivolol, can affect blood pressure and/or heart function.
Insucor with food and drinks
See section 3.
Pregnancy and breastfeeding
Pregnancy
Insucor should not be administered during pregnancy unless clearly necessary.
Breastfeeding
Its use is not recommended during breastfeeding.
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
This medication may cause dizziness or fatigue. If this occurs,do notdrive or operate machinery.
Insucor contains lactose
This medication containslactose. Ifyour doctor has told you that you have a certain sugar intolerance,consultbefore taking this medication.
Insucor contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Insucor can be taken before, during, or after meals, but it can also be taken independently of them. It is preferable to take the tablet with a little water.
Treatment of high blood pressure (hypertension)
Treatment of chronic heart failure
Your doctor will closely monitor your treatment.
Your doctor may decide that it is necessary to combine these tablets with other medications to treat your condition.
If your doctor has instructed you to take ½ (half) tablet daily, consult the instructions below on how to break Insucor 2.5 mg and Insucor 5 mg tablets into equal doses.
• Place the tablets on a flat, hard surface (e.g., a table or countertop), with the score line facing upwards.
• Break the tablet by pushing it with your index fingers from both hands along the score line (Diagrams 1 and 2).
Diagram 1Diagram 2
Diagrams 1 and 2: easy breaking of Insucor 2.5 mg and Insucor 5 mg tablets into equal doses.
Use in children and adolescents
Do not use it in children or adolescents.
If you take more Insucor than you should
If you have accidentally taken an overdose of this medication, consultimmediatelyyour doctor or pharmacist or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount taken. The symptoms and signs reported most frequently with an overdose are related to a very slow heart rate (bradycardia), low blood pressure with possible fainting (hypotension), difficulty breathing such as in asthma (bronchospasm), and acute heart failure.
You can take activated charcoal (available at your pharmacy) while waiting for your doctor to arrive.
If you forget to take Insucor
If you forget to take a dose of Insucor, but remember shortly after when you should have taken it, take the daily dose as usual. If a lot of time has passed (several hours), so that you are near the next dose, skip the missed dose and take the nextplanned dose,at the usual time. Do not take a double dose. However, you should try to avoid repeated missed doses of the medication.
If you interrupt treatment with Insucor
Always consult your doctor before interrupting treatment with Insucor, whether you are taking it for high blood pressure or chronic heart failure.
You must not stop treatment abruptly, as this could temporarily worsen your heart failure.
If it is necessary to interrupt treatment for chronic heart failure, the daily dose should be gradually reduced, halving the dose at weekly intervals. If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking nebivolol and talk to your doctor immediately if you have any of the following side effects:
When InsuCoris used to treat high blood pressure, its possible side effects are:
Frequent side effects (may affect up to 1 in 10 people):
Rare side effects (may affect up to 1 in 100 people):
Very rare side effects (may affect up to 1 in 10,000 people):
The following side effects have been reported in isolated cases during treatment with this medicine:
In a clinical study forchronic heart failure, the following side effects were observed:
Frequent side effects (may affect more than 1 in 10 people):
Frequent side effects (may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly to the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the blister pack after CAD.
The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.If the medication loses its color or shows any signs of deterioration, ask your pharmacist for advice, who will tell you what to do.
Composition of Insucor
The active ingredient is nebivolol.
Each tablet contains 2.5 mg of nebivolol, equivalent to 2.725 mg of nebivolol hydrochloride.
The other components are:
Lactose monohydrate, cornstarch, sodium croscarmellose, hypromellose, microcrystalline cellulose, anhydrous colloidal silica, and magnesium stearate.
Appearance of the product and contents of the package
Biconvex, non-coated tablets, in the form of a capsule, white in color, with a notch on one side and smooth on the other. The tablets can be divided into equal doses.
Insucor tablets are presented in blisters containing 14, 28, 30, 50, 90, 98, 100 tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Glenmark Arzneimittel GmbH
Industriestr. 31
82194 Gröbenzell
Germany
Responsible manufacturer:
Glenmark Pharmaceuticals s.r.o.
Fibichova 143
56617 Vysoke Myto
Czech Republic
Glenmark Generics (Europe) Ltd.
The Old Sawmill, Hatfield Park
Hatfield, Herts., AL9 5PG
United Kingdom
For more information about this medication, please contact the local representative of the marketing authorization holder:
Viso Farmacéutica, S.L.U.
c/ Retama 7, 7ª Planta
28045 Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
GermanyNebivolol Glenmark 2.5 mg tablets
HungaryNebitrix 2.5 mg
NetherlandsNebivolol Glenmark 2.5 mg tablets
SlovakiaNebitrix 2.5 mg
SpainINSUCOR 2.5 mg tablets
Last review date of this leaflet: April 2025
More detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es//
The average price of Insucor 2,5 mg comprimidos in July, 2025 is around 3.93 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.